On Wednesday, Shares of Teva Pharmaceutical Industries Ltd (ADR)(NYSE:TEVA), subtract -0.15% and closed at $45.19 in the last trading session. The last trading range of the stock ranges between $44.60 and $45.95. The company’s Market capitalization is $48.15 Billion with the total Outstanding Shares of 1.01 Billion. Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) recently declared that it has agreed to sell assets and operations of Actavis Generics in the UK and Ireland to Accord Healthcare Limited (a partner of Intas Pharmaceuticals Ltd) for an agreed value of GBP 603 million, subject to final approval from the European Commission.
The divestment of certain specified Actavis Generics assets and operations in the UK and Ireland was part of an undertaking that Teva made to the European Commission in the context of the review of the acquisition of Actavis Generics by Teva earlier this year. The sale will include a portfolio of generic medicines plus a manufacturing plant in Barnstaple, England. Teva retains a number of Actavis non-overlapping generic products plus certain specialty medicines and OTC (over-the-counter) products, which have been added to Teva’s existing operations.
News Corp (NASDAQ:NWSA), jumped 2.38% and closed at $14.62 in the last trading session. The last trading range of the stock ranges between $14.23 and $14.68. The company’s Market capitalization is $8.48 Billion with the total Outstanding Shares of 380.54 million. News Corp declared recently that John Elkann will step down from the Board of Directors of the company, effective right away.
Mr. Elkann, Chairman and Chief Executive Officer of EXOR S.p.A., has been a member of the Board since the launch of the “new” News Corp as an independent, publicly traded company following the separation of its businesses from 21st Century Fox in June 2013.
“With his vision and good judgment, John Elkann has been a noteworthypart of our company’s progress. I am grateful for his friendship, and for all he’s done for us at News Corp,” said Executive Chairman Rupert Murdoch.
“On behalf of everyone at News Corp, I salute John for his steadfast support over the past three years of our development,” said Chief Executive Robert Thomson. “We are a stronger company recently, with greater digital prowess and a diverse, global presence, thanks in no small measure to John Elkann’s astute insights.”
Masco Corp (NYSE:MAS), gained 1.12% and closed at $34.24 in the last trading session. The last trading range of the stock ranges between $34.03 and $34.46. During the 52-week trading session the minimum price at which share price traded, registered at $23.10 and reached to max level of $34.46. Masco Corporation (MAS) declared recently that it will hold a conference call regarding 2016 third quarter results on Tuesday, October 25, 2016 at 8:00 a.m. ET. The conference call will be hosted by Masco President and Chief Executive Officer Keith Allman. Participants in the call are asked to register five to ten minutes before the planned start time by dialing (855) 226-2726 (855-22MASCO) and from outside the U.S. at (706) 679-3614. Please use the conference identification number 86755759.
The 2016 third quarter results and supplemental material will be distributed at 7:00 a.m. ET on October 25, 2016 and will be available on the Company’s website.